1,3,4,7-tetrahydro-2h-pyrrolo[3',2':5,6]pyrido[2,3-b][1,4]oxazepine bcl-2 inhibitors
US-2026028356-A1 · Jan 29, 2026 · US
This page is not indexed by search engines while we improve data quality.
Patent family 85382827
This patent family groups 4 related publications across US. Members often share priority claims or equivalent filings in different countries.
| Field | Value |
|---|---|
| Family ID | 85382827 |
| Family type | — |
| Earliest priority | Jan 21, 2022 |
| First filing country | US |
| Member publications | 4 |
| Countries | US |
| Representative publication | US2026028356A1 — 1,3,4,7-tetrahydro-2h-pyrrolo[3',2':5,6]pyrido[2,3-b][1,4]oxazepine bcl-2 inhibitors |
Representative publication
Best representative member for this family based on priority and filing country.
US2026028356A1 — 1,3,4,7-tetrahydro-2h-pyrrolo[3',2':5,6]pyrido[2,3-b][1,4]oxazepine bcl-2 inhibitors (published Jan 29, 2026)
Member publications
Related publications in this family.
1,3,4,7-tetrahydro-2h-pyrrolo[3',2':5,6]pyrido[2,3-b][1,4]oxazepine bcl-2 inhibitors
US-2025066388-A1 · Feb 27, 2025 · US
1,3,4,7-tetrahydro-2H-pyrrolo[3′,2′:5,6]pyrido[2,3-b][1,4]oxazepine bcl-2 inhibitors
US-11964990-B2 · Apr 23, 2024 · US
1,3,4,7-Tetrahydro-2H-pyrrolo[3',2':5,6]pyrido[2,3-b][1,4]oxazepine Bcl-2 Inhibitors
US-2023234971-A1 · Jul 27, 2023 · US